BUSINESS COMBINATION AND DECONSOLIDATION OF SUBSIDIARY (Details Narrative) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Oct. 21, 2020	Mar. 31, 2022
Purchase price for the acquisition		$ 14.2
Closing Merger Consideration Shares, shares		6,909,091
Contingent Consideration Shares (Clawback Shares), shares		5,988,024
Aggregate amount		$ 20.0
Acquisition descriptions		The Company acquired Sera Labs through the issuance of shares of Common Stock of the Company with $1 million of cash consideration to be provided. The preliminary total purchase price was determined based on the following: i) $1 million of the Upfront Payment ii) Company’s closing price ($1.38) on October 2, 2020 for the closing merger consideration shares
Upfront payment consideration		1,000,000.0
Upfront payment in cash	$ 1.0
Working capital		$ 4.0
Aggregate maximum milestones amount	$ 20.0
Potential shares to be issued	5,988,024
Fair value of contingent shares	$ 3.1
CHI [Member]
Total purchase price, shares	12,897,115